Adaptive Biotechnologies eyes 'strategic alternatives' for its 2 businesses

Seattle-based Adaptive Biotechnologies has hired Goldman Sachs to explore alternatives for its two businesses. "All options are on the table right now," CEO Chad Robins said.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 22, 2023 Category: Pharmaceuticals Authors: Rick Morgan Source Type: news